ArticleScientific reports2025
Optimizing a rapid tissue culture method for steviol glycoside production from Stevia rebaudiana to address egypt's sugar deficit.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Steviol Glycosides (E960) FromFood science & nutrition · 2026Review
- In Vitro Regeneration ofGenes · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Egypt has encountered a significant sugar scarcity since 2023, due to a water crisis, which has reduced local sugar production, prompting a search for alternative sources. Stevia rebaudiana (Asteraceae) is a natural source of steviol glycosides, which are high-intensity, low-calorie sweeteners with increasing demand in food and pharmaceutical industries. Despite its potential as a water-efficient alternative to sugar crops, Egypt lacks optimized protocols for stevia propagation and secondary metabolite enhancement. This study aimed to develop an efficient in vitro regeneration system for a local stevia genotype using callus induction, as well as both direct and indirect micropropagation and to assess its impact on steviol glycoside accumulation by comparison with conventionally soil-grown plant. Explants were cultured on Murashige and Skoog (MS) media supplemented with varying concentrations of BAP, NAA, and kinetin to evaluate callus formation, shoot proliferation, and root development. Optimal conditions yielded significantly higher shoot regeneration frequencies (up to 93%) and shoot number per explant (up to 12.6). Regenerated plants were acclimatized with a survival rate exceeding 85%. Ultra-Performance Liquid Chromatography-Tandem Mass Spectrometry (UPLC-MS/MS) was used for metabolite profiling of the four studied stevia. A total of 18 compounds were detected across the four studied stevia samples, including 11 phenolic compounds, and 7 diterpenoids, primarily stevioside, rebaudioside A, and rebaudioside C. Metabolite quantification based on relative peak areas revealed that the direct micropropagation strategy yielded the highest levels of stevioside and rebaudioside A (13.17 and 5.71%, respectively), surpassing those in soil-grown plants, callus-derived and indirectly propagated samples. Multivariate data analysis was conducted to identify relationships among metabolite markers in the four studied stevia samples. The metabolite profiles of both soil-grown and regenerated through direct micropropagation stevia was found to be similar, with both being rich in steviol glycosides. Notably, the growth duration varied among the four studied stevia. The soil-grown and indirectly micropropagated stevia took 180 and 196 days to reach maturity, respectively while stevia regenerated via direct micropropagation took 140 days, demonstrating a more rapid development. These findings demonstrated that direct micropropagation not only enhances growth but also conserves metabolic integrity, and highlights it as an ideal strategy for scalable production of sweetener under resource-restricted settings in arid and semi-arid regions.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.